A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 379 shares of NVS stock, worth $40,981. This represents 0.01% of its overall portfolio holdings.

Number of Shares
379
Previous 384 1.3%
Holding current value
$40,981
Previous $38.8 Million 1.75%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$95.27 - $108.47 $476 - $542
-5 Reduced 1.3%
379 $38.1 Million
Q3 2023

Nov 08, 2023

BUY
$94.73 - $105.13 $36,376 - $40,369
384 New
384 $39.1 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Annis Gardner Whiting Capital Advisors, LLC Portfolio

Follow Annis Gardner Whiting Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annis Gardner Whiting Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annis Gardner Whiting Capital Advisors, LLC with notifications on news.